What is Mass Automation?
Mass Automation operates at the intersection of advanced robotics and industrial systems engineering. The company specializes in the design, manufacturing, and integration of custom automation equipment tailored for complex sectors such as pharmaceuticals and medical device production. By providing end-to-end services—ranging from initial on-site application assessments to the retrofitting of legacy machinery—Mass Automation enables its clients to achieve superior operational efficiency. Their core value proposition lies in the delivery of bespoke, cost-effective automation solutions that directly address the challenges of human resource optimization and production throughput in highly regulated environments.
How much funding has Mass Automation raised?
Mass Automation has raised a total of $71K across 1 funding round:
Debt
$71K
Debt (2021): $71K with participation from PPP
Key Investors in Mass Automation
PPP
Public-Private Partnership
What's next for Mass Automation?
With the recent influx of capital, Mass Automation is poised to accelerate its strategic roadmap, focusing on the development of next-generation application-specific machinery. The company is expected to prioritize the expansion of its engineering team and the enhancement of its manufacturing facilities to meet the rising demand for automated pharmaceutical processing. As the firm transitions through this significant Series B/C stage, the focus will likely shift toward scaling its service delivery model and deepening its market penetration in the medical technology sector. This investment serves as a critical catalyst for long-term innovation, allowing the company to refine its proprietary automation frameworks and maintain its competitive edge in the global industrial landscape.
See full Mass Automation company page
